Pharmaceutical plant generally use what equipment

Pharmaceutical equipment refers to chemical raw materials and pharmaceuticals, Chinese medicine tablets and proprietary Chinese medicine production equipment, we can be used in accordance with the purpose, subdivided into API equipment and machinery, preparation machinery, pharmaceutical crushing machinery, tablet machinery, pharmaceutical water equipment, pharmaceutical packaging machinery, drug testing equipment, pharmaceutical auxiliary equipment, which is eight types. With the development of the pharmaceutical industry, China's pharmaceutical equipment industry has also maintained a rapid growth, the next and Xiaobian to understand it.

What are the types of pharmaceutical machinery and equipment

Pharmaceutical equipment is used for the production of pharmaceutical machinery and equipment, including crushers, slicers, frying machines, decoction machines, tablet presses, pill making machines, multi-functional extraction tanks, liquid storage tanks, liquid dispensing tanks, decompression drying oven, tilting reactor pots, capsule filling machines, blister packaging machine, granule packaging machine, bulk packaging machine, V-type mixing machines, lifting feeding machine, etc. These equipments can be subdivided into eight types according to their applications: API equipments and machines, preparation machines, pharmaceutical crushing machines, drinking machines, pharmaceutical water equipments, pharmaceutical packaging machines, drug testing equipments and pharmaceutical auxiliary equipments.

The picture is provided by the registered user "technology digital line", copyright statement feedback

How is the development of pharmaceutical equipment

Pharmaceutical industry is an important part of China's national economy, China's pharmaceutical industry has been maintaining rapid growth, especially with the accelerated process of health care reform and health care investment growth and national health care awareness, the scale has been expanding, the economic operation of the pharmaceutical industry has been maintained, especially with the accelerated process of health care reform and health care investment growth and national health care awareness, the economic operation of the pharmaceutical industry has been maintained, the economic operation of the pharmaceutical industry has been maintained. The scale has been expanding, and the quality and efficiency of economic operation have been improving.

With the development of the pharmaceutical industry, China's pharmaceutical equipment industry has also maintained a faster growth. First of all, in terms of pharmaceutical safety, the "National Pharmaceutical Industry Twelfth Five-Year Development Plan" put forward to the full implementation of the new version of the GMP, and strict implementation of the GMP, significantly improve the overall level of quality management of China's pharmaceuticals. Encourage conditional enterprises to carry out GMP certification in developed countries or WHO, driving China's drug quality management and international standards.In December 2011, the EU officially promulgated Directive 2011/62/EU, raising the threshold for drug imports.

The EU is the largest export market for chemical pharmaceutical products in China. Although the newly implemented GMP standards in China cover the basic requirements of the EU, US FDA and WHO for GMP, with reference to the EU standards for hardware and US FDA standards for software, and the degree of strictness is unprecedented in the history of China's pharmaceutical industry, the Chinese pharmaceutical exporters with GMP accreditation from both the PRC and the EU have been recognized by both the EU and China. However, among the Chinese pharmaceutical export enterprises, only a few large enterprises have the GMP recognition from both China and EU. Therefore, the promulgation of the new standard will certainly cause the export enterprises to accelerate their production transformation and upgrading.

In the EU the introduction of the new version of the GMP standard, China's new version of the GMP began to be fully implemented as well as the pharmaceutical environmental protection requirements to improve the background of the future growth rate of the market capacity of the API market will be better performance, on the one hand, China's exports to the European Union market of western pharmaceuticals in the APIs accounted for about 50% of the proportion of a larger proportion. On the other hand, the API is the pharmaceutical companies in the most serious environmental pollution module, so its environmental investment needs are also greater.